BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06106308-completion@plaintrial.com
DTSTAMP:20261027T055611Z
DTSTART;VALUE=DATE:202701
SUMMARY:Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or
  FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevac
 izumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult P
 articipants With a KRAS or NRAS Mutation — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06106308
URL:https://plaintrial.com/trial/NCT06106308
END:VEVENT
END:VCALENDAR